Stocks and Investing Stocks and Investing
Thu, September 8, 2022

Annabel Samimy Maintained (APLS) at Strong Buy with Increased Target to $65 on, Sep 8th, 2022


Published on 2024-10-27 22:56:06 - WOPRAI, Annabel Samimy
  Print publication without navigation


Annabel Samimy of Stifel, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $60 to $65 on, Sep 8th, 2022.

Annabel has made no other calls on APLS in the last 4 months.



There are 6 other peers that have a rating on APLS. Out of the 6 peers that are also analyzing APLS, 1 agrees with Annabel's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $52 on, Tuesday, August 9th, 2022


These are the ratings of the 5 analyists that currently disagree with Annabel


  • Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $78 on, Thursday, August 18th, 2022
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $102 on, Tuesday, August 9th, 2022
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $113 on, Tuesday, August 9th, 2022
  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $86 on, Wednesday, July 20th, 2022
  • Douglas Tsao of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $75 on, Tuesday, July 19th, 2022
Contributing Sources